This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Preliminary Schedule

*Subject to Change

Friday, February 28, 2020

  • 07:00 19:00

    Registration/ Inscription

    Room: Fortifications Foyer

  • 07:00 08:00

    Breakfast/Petit Déjeuner

    Room: Fortifications

  • 07:15 19:30

    9th Canadian Symposium on Hepatitis C Virus

    Advances in HCV Research and Treatment Towards Elimination

  • 08:00 08:15

    Welcome and Introductions | Mot de Bienvenue

    Room: Montreal CD

    Curtis Cooper (Symposium Chair) | The Ottawa Hospital Research Institute
    Angela Crawley (Symposium Co-Chair) | The Ottawa Hospital Research Institute

  • 08:15 09:15

    Biomedical Research ‑ HCV Vaccine Development and Related Studies

    Room: Montreal CD

    Seung-Hwan Lee (Co-Chair) | University of Ottawa 
    Che Colpitts (Co-Chair) | Queens University
    CanHepC trainees introducing Plenary Speakers  | Chisom Okwor and Vanessa Meier-Stephenson

    8:15 - 8:35 | Session - Vaccines for HCV - Where there is a Will there is a Way | Ellie Barnes | Oxford University, UK
    8:35 - 8:55 | Session - Progress towards a Global Prophylactic HCV Vaccine | John Law | University of Alberta, Canada
    8:55 - 9:15 | Questions/Panel Discussion 

  • 09:15 09:45

    Oral Presentations

    Room: Montreal CD

    9:15 - 9:30 | Oral Abstract 1 | Differential gene expression of circulating CD8 T cells of cirrhotic HCV-infected individuals identifies pathways associated with lasting dysfunction | Angela M. Crawley | Ottawa Hospital Research Institute

    9:30 - 9:45 | Oral Abstract 2 | The Effect of Apoptosis and Inflammasome-Mediated Pyroptosis on HCV Infection | Hannah Louise Wallace | Memorial University

  • 09:30 19:30

    Exhibition Hours

    Room: Fortifications

  • 09:45 10:00

    Coffee Break | Pause Café and Poster Browsing

    Room: Fortifications

  • 10:00 11:00

    Social, Cultural, Environmental, and Population Health Research – HCV in Underserved Populations: Modeling and Real‑Life Data to Inform Strategies

    Room: Montreal CD

    Julie Bruneau (Co-Chair) | Université de Montréal
    Nadine Kronfi (Co-Chair) | McGill University
    CanHepC trainees introducing Plenary Speakers  | Adam Palayew and Yasmin Saeed


    10:00 - 10:20 | Session: Tackling HCV transmission among people who inject drugs: insights from modeling - Natasha Martin | University of California San Diego, USA

    10:20 - 10:40 | Session: Hepatitis C Virus (HCV) Care in Canadian Correctional Facilities: The long road ahead towards HCV elimination - Nadine Kronfi | McGill University

    10:40 - 11:00 | Questions/Panel Discussion 

  • 11:00 11:30

    Oral Presentations

    Room: Montreal CD

    11:00 - 11:15 | Oral Abstract 1 | Effect of Sustained Virologic Response and Opioid Agonist Therapy on Mortality Among People Living with Chronic Hepatitis C | Prince Adu | University of British Columbia

    11:15 - 11:30 | Oral Abstract 2 | Community and Corrections Based Point-of-Care Testing into a Provincial Hepatitis C Elimination Framework | Lisa Barrett | Dalhousie University

  • 11:30 12:30

    Community Session ‑ “Connecting With Care”: Canadian Models of Hepatitis C Care‑ A Film Preview and Panel Discussion

    Room: Montreal CD

    Moderator: Melisa Dickie | Director, Hepatitis C Knowledge Exchange

    A Saskatchewan Story, Athakakoop Health Centre 
    Jodie Albert | Outreach Worker, Tanys Isbister, Community Health Nurse

    Montreal’s Many Models of Care 
    Martin Pagé | Executive Director, Dopamine
    Hugo Bissonne | Executive Director, Centre Sida Amitié
    Robert LaMarche | Outreach Worker, Centre Sida Amitié

    Toronto Community Hep C Program 
    Jennifer Broad | Community Health Worker
    Kate Mason | Researcher
    Jason Altenberg | CEO, South Riverdale Community Health Centre.

  • 12:30 14:00

    Lunch and Poster Session | Présentation des Affiches

    Room: Fortifications

    13:00 - 13:45 | CanHepC evaluation of poster

  • 14:00 14:55

    Clinical Research ‑ Hepatitis C Infection in Pregnancy & Children

    Room: Montreal CD

    Eve Roberts (Co-Chair) | Dalhousie University
    Hugo Soudeyns (Co-Chair) | Université de Montréal
    CanHepC trainees introducing Plenary Speakers:  Nanor Minoyan and Gillian Kolla

    14:00 - 14:20 | DAA use in Pregnancy - Robert Honegger | Nationwide Children's, USA
    14:20 - 14:40 | Pediatric Perspectives on DDA Use - Simon Ling | University of Toronto, Canada
    14:40 - 14:55 | Questions/Panel Discussion

  • 14:55 15:25

    Oral Presentations

    Room: Montreal CD

    14:55 - 15:10 | Oral Abstract 1 | Efficacy of Sofosbuvir/Velpatasvir (S/V): Impact of Treatment Adherence | Brian Conway

    15:10 - 15:25 | Oral Abstract 2 | Reinfection Following Successful Direct-Acting Antiviral Therapy for Hepatitis C Infection Among People Who Inject Drugs | Evan Cunningham | The Kirby Institute, UNSW, Sydney, Australia

  • 15:25 16:10

    Health Services Research – Blueprint Update and Implementation

    Room: Montreal CD

    Jason Altenberg (Co-Chair) | South Riverdale Community Health Centre
    Naveed Janjua (Co-Chair) | BCCDC

    15:25 - 15:35 | Blueprint Update | Jordan Feld | University of Toronto, Canada

    15:35 – 15:55 | Elimination Efforts in Nova Scotia and Prince Edward Island | Lisa Barrett | Dalhousie University, Halifax, Canada

    15:55 – 16:10 | Questions/Panel Discussion

  • 16:10 16:40

    Oral Presentations

    Room: Montreal CD

    16:10 - 16:25 | Oral Abstract 1 | HBV-HCV Co Infection Among Immigrants in Ontario, Canada |Abdool S. Yasseen | University of Toronto, Canada

    16:25 - 16:40 | Oral Abstract 2 | The Health Burden of Hepatitis C Infection Facing the First Nations Population in Ontario: A Province-Wide Descriptive Analysis | Andrew Mendlowitz | University of Toronto, Canada

  • 16:40 16:50

    CanHepC Trainee Awards Ceremony

    Room: Montreal CD

    Christopher Richardson

  • 16:50 16:55

    CanHepC Symposium Closing Remarks

    Room: Montreal CD

    Curtis Cooper | The Ottawa Hospital Research Institute
    Angela Crawley | The Ottawa Hospital Research Institute

  • 16:55 17:05

    Canadian Liver Meeting Opening Remarks

    Room: Montreal CD

    Marc Bilodeau | Université de Montreal, Montreal, Canada

  • 17:05 17:40

    CLM Opening Presentation ‑ Update on HCV Elimination in Canada and the US

    Room: Montreal CD

    Andrew Aronsohn | University of Chicago 

  • 17:40 19:30

    Joint CanHepC and Canadian Liver Meeting Reception and CanHepC Poster Viewing

    Room: Fortifications

  • 18:10 18:25

    Biomedical Poster Tour

    Room: Fortifications

    Chair: Rasika Kunden | CanHepC Trainee

    18:10 - 18:15: Sophie Cousineau | Poster No: CHC - P - 001 | Identifying the Role Played by the Poly(rC)-Binding Protein 2 (PCBP2) in the HCV Life Cycle

    18:15 - 18:20: Catia Perciani | Poster No: CHC - P - 004 | Precision-Cut Liver Slice (PCLS) Culture: A Model to Examine HCV Interactions with the Liver Microenvironment

    18:20 - 18:25 – Mohamed AbdelnabiPoster No: CHC - P - 006 | Neutrophils are the major producers of the pro-fibrogenic cytokine IL-17A in non-alcoholic fatty liver disease (NAFLD)

  • 18:10 18:25

    Social, Cultural, Environmental and Population Health Poster Tour

    Room: Fortifications

    Chair: Zoe Greenwald | CanHepC Trainee

    18:10 - 18:15: Adam Palayew | Poster No: CHC - P - 016 | Estimation of an Individual-Level Deprivation Index for HIV/HCV Coinfected Persons 

    18:15 - 18:20: Adelina ArteniePoster No: CHC - P - 013 |  Diversity of Detention Patterns among People who Inject Drugs and the Associated Risk with Incident Hepatitis C Virus (HCV) Infection: Implications for Hepatitis C Prevention 

    18:20 - 18:25: Sofia BartlettPoster No: CHC - P - 012 |  Increasing Hepatitis C Screening & New Diagnoses in 10 British Columbia Provincial Correctional Centres from 2010-2019

  • 18:35 19:00

    Clinical Poster Tour

    Room: Fortifications

    Chair: Jordan Feld | CanHepC Mentor

    18:35 - 18:40: Y. Mendoza | Poster No: CHC - P - 029 | Non-Invasive Surrogates of Portal Hypertension Predict Decompensation in Obese Patients with Compensated Ddvanced Chronic Liver Disease

    18:40 - 18:45: Valerie Martel-Laferriere Poster No: CHC - P - 031 | Universal HCV and HIV Screening in an Emergency Room – Fewer New Cases than Expected

    18:45 - 18:50: Curtis CooperPoster No: CHC - P - 032 | DAA Treatment Uptake or Outcomes are Not Effected by Alcohol Use: A CANUHC Analysis

  • 18:35 19:00

    Health Services Research Poster Tour

    Room: Fortifications

    Chair: Lisa Barrett | CanHepC Mentor

     18:35 - 18:40: William Wong | Poster No: CHC - P - 033 | Can we Afford to Screen and Treat Hepatitis C Virus (HCV) Infection in Canada? Latest Insight from a Canadian Policy Model – A Province-by-Province Analysis

    18:40 - 18:45: Gisela MacphailPoster No: CHC - P - 038 | Hepatitis C (HCV) Re-Engagement Strategy after Loss to Follow-up

    18:45 - 18:50: Yasmin SaeedPoster No: CHC - P - 036 |  Disparities in Health Utilities among Hepatitis C Patients Receiving Care in Different Settings